Redhill Biopharma Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Redhill Biopharma Ltd., a foreign private issuer based in Tel Aviv, Israel, for the month of December 2012. The filing incorporates by reference a press release announcing the company's listing on the NASDAQ stock market and the commencement of trading under the ticker symbol "RDHL."
Financial Metrics
The filing text does not provide specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The primary material change reported is the successful listing of the company's securities on the NASDAQ Global Market. This represents a significant milestone in the company's capital market status compared to the prior period.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors beyond the standard incorporation of the press release regarding the listing. No unusual items or contingencies are detailed in the text provided.
Key Facts for Investor Verification
- Verify the commencement of trading on NASDAQ under the ticker "RDHL" as of late December 2012.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that this specific filing contains no financial statements; investors should refer to the company's Form 20-F for detailed financial metrics.